Brief: Biomed Lublin Signs Construction Deal With Karmar For Onko BCG Production Plant
21/07/2022 12:53
July 21 (Reuters) - Biomed Lublin Wytwornia Surowic i
Szczepionek SA BML.WA :
* SIGNS CONSTRUCTION DEAL WITH KARMAR FOR ONCO BCG
PRODUCTION
PLANT
* LUMP SUM REMUNERATION FOR KARMAR UNDER DEAL AT 69.0
MILLION
ZLOTYS
Source text for Eikon: ID:nEM4JRmzMa
Further company coverage: BML.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility